Measuring Patient Expectations for Thyroid Surgery

Active, not recruiting

• Conditions: Thyroid Cancer
• Interventions: Behavioral: patient interviews; Behavioral: CITSAV survey

• Registration Number: NCT01412762
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to learn more about what patients undergoing surgery for thyroid cancer expect from their surgery. Your input may help us to better prepare and inform patients about their disease and its treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-07
• Study First Submitted: 2011-08-03
• Study First Submitted QC: 2011-08-08
• Study First Posted: 2011-08-09
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-19
• Last Update Posted: 2023-10-23
• Primary Completion: 2024-07
• Study Completion: 2024-07

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 138

Inclusion Criteria

• Age ≥18 years
• English speaking
• Patients with confirmed thyroid malignancy confirmed by preoperative fine needle biopsy (any stage) planned for surgical excision

Read More

Exclusion Criteria

• Inability to speak or understand English
• Inability to provide meaningful informed consent due to physical, cognitive, or psychiatric disability
• Prior thyroid surgery
• Prior radioactive iodine treatment, external beam radiation or chemotherapy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patient interviews	patient interviews	We aim to interview 15 patients with confirmed thyroid malignancy both pre- and postoperatively, for a total of 30 interviews. For the expansion of this study, we will accrue 25 patients with biopsy-proven thyroid cancer undergoing thyroidectomy to be educated with the CITSAV application prior to surgery.
patient interviews	CITSAV survey	We aim to interview 15 patients with confirmed thyroid malignancy both pre- and postoperatively, for a total of 30 interviews. For the expansion of this study, we will accrue 25 patients with biopsy-proven thyroid cancer undergoing thyroidectomy to be educated with the CITSAV application prior to surgery.

Primary Outcome Measures

Name	Time	Method
To establish a patient-reported outcomes tool for measuring preoperative expectations in patients undergoing surgery for thyroid cancer.	2 year	This will be done by conducting qualitative semistructured interviews with 15 thyroid cancer patients (pre- and postoperatively) to identify recurring themes about their expectations regarding thyroid surgery.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States